药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Econazole
Frovocimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Frovocimab.
Econazole
Abrilumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Abrilumab.
Econazole
Ipafricept
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Ipafricept.
Econazole
Tafasitamab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Tafasitamab.
Econazole
Apomab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Apomab.
Econazole
Gremubamab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Gremubamab.
Econazole
Pateclizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pateclizumab.
Econazole
Dalantercept
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Dalantercept.
Econazole
Margetuximab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Margetuximab.
Econazole
Opicinumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Opicinumab.
Econazole
Pamrevlumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Pamrevlumab.
Econazole
Bermekimab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bermekimab.
Econazole
Refanezumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Refanezumab.
Econazole
Bevacizumab zirconium Zr-89
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bevacizumab zirconium Zr-89.
Econazole
Emactuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Emactuzumab.
Econazole
Parsatuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Parsatuzumab.
Econazole
Vobarilizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Vobarilizumab.
Econazole
Lintuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Lintuzumab.
Econazole
Xentuzumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Xentuzumab.
Econazole
Brolucizumab
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Brolucizumab.